Alerts will be sent to your verified email
Verify EmailDESHRAK
|
Desh Rakshak Aushdh
|
Venmax Drugs&Pharma
|
Omkar Pharmachem
|
|
|---|---|---|---|
|
Operational Metrics
|
|||
|
Financials
|
|||
|
5 yr Average ROE
|
4.74 % | 1.17 % | 2.2 % |
|
5yr average Equity Multiplier
|
1.73 | 0.08 | 1.05 |
|
5yr Average Asset Turnover Ratio
|
0.39 | 0.14 | 0.05 |
|
5yr Avg Net Profit Margin
|
7.09 % | -19.62 % | 44.95 % |
|
Price to Book
|
1.51 | 1.49 | 0.52 |
|
P/E
|
34.72 | 85.63 | 157.52 |
|
5yr Avg Cash Conversion Cycle
|
-280.35 Days | 288.55 Days | 49.27 Days |
|
Inventory Days
|
36.63 Days | 5.2 Days | 0.0 |
|
Days Receivable
|
363.29 Days | 430.69 Days | 49.27 Days |
|
Days Payable
|
408.55 Days | 141.12 Days | 0.0 |
|
5yr Average Interest Coverage Ratio
|
2.89 | -260.56 | 7.4 |
|
5yr Avg ROCE
|
6.6 % | -47.43 % | 2.6 % |
|
5yr Avg Operating Profit Margin
|
19.52 % | -65.91 % | 44.39 % |
|
5 yr average Debt to Equity
|
0.38 | -0.45 | 0.06 |
|
5yr CAGR Net Profit
|
2.71 % | -42.57 % | -1.89 % |
|
5yr Average Return on Assets
|
2.74 % | 199.45 % | 2.09 % |
|
Shareholdings
|
|||
|
Promoter Holding
|
50.03 % | 13.8 % | 0.03 % |
|
Share Pledged by Promoters
|
0.0 | 0.0 | 0.0 |
|
Change in Promoter Holding (3 Yrs)
|
-14.25 % | -9.33 % | 0.0 |
|
Change in Mutual Fund Holding (3 Yrs)
|
0.0 | 0.0 | 0.0 |
|
Desh Rakshak Aushdh
|
Venmax Drugs&Pharma
|
Omkar Pharmachem
|
|
|---|---|---|---|
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|